Company Overview and News

1
Offshore drillers eye recovery by 2020

3h reuters
Oct 15 (Reuters) - Battered oil and gas drilling companies are finally seeing piecemeal signs that the prices they charge for offshore rigs are bottoming out with Brent crude selling for more than $80 a barrel and some are forecasting a full turn in the market by 2020.
RDS.B NOBGF RDS.A RDSB RDSA ORIG ATW N21 CVX NOBGY RYDBF RYDAF RIG SGAZF

6
Noble Corp.: October Fleet Status And Backlog Analysis

16h seekingalpha
Noble announced two gigs for two idle drillships and acquired a new jack-up which comes with a three-year contract in the Middle East.
TALO NE NOBGF N21 NOBGY

 
Noble Corp. October Fleet Status Report Analysis

2018-10-12 seekingalpha
Two drillships get short-term work. The news is cash flow positive since these rigs will continue to get idle rates from existing contracts with other operators.
NE NOBGF N21 NOBGY

51
How Fragmented Is The Offshore Drilling Industry?

2018-10-11 seekingalpha
I look at raw data. There are at least 125 offshore drilling companies out there, and many of them are still able to compete.
SDLP NE ESV NOBGF PACDQ N21 NOBGY SDRL RIG

 
Stocks to watch: Singtel, Nam Cheong, Noble, Duty Free International

2018-10-11 businesstimes.com.sg
Singtel: Its Australian subsidiary has inked a deal to buy a privately held cyber security firm incorporated in Victoria state, which will be integrated into the group's Trustwave cybersecurity arm. Optus Cyber Security will pay up to A$23.3 million (S$22.9 million) for three-year-old Hivint, subject to earn-out targets and adjustments such as working capital and cash at closing, in a conditional agreement announced by the group on Wednesday evening.
NCMHF 5FL BMT NOBGF N4E N21 NOBGY 5SO

 
Yancoal to file legal objection to Noble's restructuring

2018-10-10 businesstimes.com.sg
NOBLE Group on Wednesday flagged that Yancoal Australia and certain of Yancoal's affiliates intend to file objections to the constitution of classes and the schemes under the restructuring plan put out by the commodities firm.
YACAF NOBGF N21 NOBGY YAL

 
Stocks to watch: Noble, Lafe Corp, Addvalue Tech, Q&M

2018-10-10 businesstimes.com.sg
Noble Group: Noble on Wednesday flagged that Yancoal Australia Ltd and certain of Yancoal's affiliates intend to file objections to the constitution of classes and the schemes under the restructuring plan put out by the commodities firm. Yancoal, which is labelled as a potential "other scheme creditor", is also set to challenge the jurisdiction of the English courts.
YACAF NOBGF A31 N21 NOBGY YAL

 
Noble divests Indonesian subsidiary for nominal payment of US$1

2018-10-10 businesstimes.com.sg
TROUBLED commodities trader Noble Group sold its beneficial interests in an Indonesian subsidiary for a nominal US$1 in cash on Wednesday, with the buyer also taking on all the outstanding payables owed.
NOBGF N21 NOBGY

 
Noble flags objection from Yancoal over terms of restructuring plan

2018-10-10 businesstimes.com.sg
NOBLE Group on Wednesday flagged that Yancoal Australia Ltd and certain of Yancoal's affiliates intend to file objections to the constitution of classes and the schemes under the restructuring plan put out by the commodities firm.
YACAF NOBGF N21 NOBGY YAL

 
Ensco, Rowan Tie The Knot In An All-Stock Deal

2018-10-09 seekingalpha
Offshore drillers Ensco and Rowan announced an all-stock merger agreement creating a combined company with a total of 82 rigs.
ATW RDC ESV NOBGF N21 NOBGY BDRLF ORIG

 
Diamond Offshore: Looking At M&A Perspectives After Ensco/Rowan Merger

2018-10-09 seekingalpha
Ensco/Rowan merger sparks speculation about who will be the next one to make a move in the offshore drilling space.
DO ATW RDC NE ESV NOBGF PACDQ N21 NOBGY RIG

46
Noble Corporation: Looking At M&A Perspectives After Ensco/Rowan Deal

2018-10-08 seekingalpha
Ensco/Rowan merger heats up discussion in the offshore drilling space - who's next among big players?
NE ESV NOBGF N21 NOBGY SDRL RIG BDRLF

 
Barnes & Noble shares could have more upside: Barron's

2018-10-07 channelnewsasia
Shares of Barnes & Noble Inc could still have more upside after a jump in the stock this week on news the bookseller is exploring strategic options, according to Barron's.
NOBGF N21 NOBGY

 
Barnes & Noble shares could have more upside: Barron's

2018-10-07 reuters
(Reuters) - Shares of Barnes & Noble Inc (BKS.N) could still have more upside after a jump in the stock this week on news the bookseller is exploring strategic options, according to Barron’s.
NOBGF N21 NOBGY

 
Diamond Offshore Announces New Credit Facility

2018-10-05 seekingalpha
The banks remain cautious despite the rising oil prices, but the new facility compares favorably to the one received by Transocean, highlighting the strength of Diamond Offshore's balance sheet.
NE ESV NOBGF N21 NOBGY RIG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 65504R104